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Proteomic proﬁles of RAST+ subjects with severe food allergies and RAST− subjects were compared using 2D-DIGE analysis
to obtain candidate biomarkers speciﬁc to food allergies. Our analysis highlighted 52 proteins that were diﬀerentially expressed
between the RAST+ and RAST− groups of which 37 were successfully identiﬁed that include chondroitin sulfates, zinc ﬁnger
proteins, C-type lectins, retinoic acid binding proteins, heat shock proteins, myosin, cytokines, mast cell expressed proteins, and
MAP kinases. Biological network analysis tool Metacore revealed that most of these regulated proteins play a role in immune
tolerance, hypersensitivity and modulate cytokine patterns inducing a Th2 response that typically results in IgE-mediated allergic
response which has a direct or indirect biological link to food allergy. Identifying unique biomarkers associated with certain
allergic phenotypes and potentially cross-reactive proteins through bioinformatics analyses will provide enormous insight into
the mechanisms that underlie allergic response in patients with food allergies.
1.Introduction
Theincreasedprevalenceoffoodallergiesisasigniﬁcantclin-
ical and public health problem in the USA. It is estimated
that in the USA alone, food-allergic reactions accounted
for over 20,000 emergency department visits, 2,300 episodes
of anaphylaxis, and over 500 hospitalizations over just a
2-month period in 2003 [1, 2]. Despite the prevalence of
food allergy, diagnosis and treatment are still far from
optimal. Eight types of food account for over 90% of allergic
reactions in aﬀected individuals: milk, eggs, peanuts, tree
nuts, ﬁsh, shellﬁsh, soy, and wheat [3, 4]. Reactions to
these foods by an allergic person can range from a tingling
sensation around the mouth and lips and hives to death,
depending on the severity of the allergy. Food allergy is
more prevalent in children than adults. Additionally, allergic
reactions to various foods often develop into allergy-related
respiratory diseases such as asthma, allergic rhinitis, and
atopic dermatitis.
Several studies provide strong evidence that both host
genetic susceptibility and environmental factors determine
the complex regulation of IgE-mediated food allergies, how-
ever, the mechanisms by which a person develops an allergy
to speciﬁc foods are largely unknown. As the IgE-mediated,
“immediatetype”foodhypersensitivityreactionsaccountfor
signiﬁcant morbidity and mortality, further understanding
of these mechanisms that contribute to the allergenicity
couldimprovetheprediction,diagnosis,andmanagementof
severity food allergy in individuals.
Food allergies are caused by IgE-dependent or IgE-
independent immunologic reactions, which then lead to
an inﬂammatory reaction, in which mast cells, eosinophilic
granulocytes, and other cells are involved. Genetic and
environmental causes predominantly underlie food allergies.2 International Journal of Proteomics
Food intolerances or nonimmunologic food incompatibili-
tiesareoftencausedbyspeciﬁcenzymedeﬁcienciesandmust
be diagnostically diﬀerentiated from food allergies. Constant
allergenexposureandotherenvironmentalfactorsdetermine
whether a sensitised individual will become chronically
allergic and experience persistent symptoms. Therapeutics
for the treatment of allergy are focused on prevention or
diminishing the speciﬁc serum immunoglobulin E (IgE) re-
sponsible for the appearance of the allergic reaction [5, 6].
Proteomic technologies play an important role in drug
discovery, diagnostics, and molecular medicine because they
are the link between genes, proteins, and disease states.
Identifying unique patterns of protein expression or
biomarkers associated with IgE-mediated food allergy is
a rapidly emerging area of clinical proteomics. Genomics
provides only a partial picture, while proteomics identiﬁes
speciﬁc proteins responding to gene expression. Progress in
protein annotation and in our understanding of protein-
protein interactions will undoubtedly lead to diagnostic
and therapeutic advances in the treatment of food allergies.
Proteomics research technologies are rapidly changing our
understanding of complex and dynamic biological systems
by providing information relevant to functionally associated
changesinproteinabundances,protein–proteininteractions,
and posttranslational modiﬁcations [7–10]. 2-dimensional
ﬂuorescence diﬀerence gel electrophoresis (2D-DIGE) has
emerged as a robust method to study protein expression
proﬁling in clinical samples. 2D gel electrophoresis can
simultaneously separate and display hundreds to thousands
of diﬀerent proteins. This method separates proteins in 2
dimensions according to their isoelectric point and their
molecular size. Fluorescent, 2-D DIGE [11–13] allows the
multiplex analysis of 3 sample proteomes on the same gel.
Data from proteomic analysis provide enormous amount
of biological information and can help establish multi-
modal markers for early diagnosis and prognosis. Addi-
tionally, these proteomic data can provide an opportunity
for identifying molecular pathways that underlie various
clinical allergic phenotypes. Identifying unique biomarkers
associated with certain allergic phenotypes, and potentially
cross-reactive proteins that can be identiﬁed through bioin-
formatics analyses will provide enormous insight into the
mechanisms that underlie allergic response in patients with
food allergies.
The current study examines the proteomic proﬁle of
ag r o u po fR A S T + subjects with severe food allergies and
compares their proteomic proﬁle with RAST− subjects. Our
goal is to not only identify biomarkers that are speciﬁc to
food allergies that result in IgE-mediated atopy but also
to identify molecular mechanism that underlie the allergic
response in patients with food allergies.
2.MaterialsandMethods
2.1. Study Design. Both pediatric and adult patients with
mild to severe food allergies who were evaluated in our
allergy clinic were informed about the research study and
some patients volunteered to participate. Institutional IRB
approval was obtained prior to commencement of the study.
Patients were consented based on the HSIRB guidelines; in
case of minors, parental consent was obtained as per the IRB
guidelines. A total of 10mL of blood sample was drawn from
the patient, of which a portion of the sample approx 3mL
was used for a RAST (Radioallergosorbent test) as a routine
clinical procedure and the remaining sample was used for
isolation of peripheral blood mononuclear cells (PBMC)
which were used for the proteomics analysis. Further, gene
expressionstudiesweredoneusingRNAwhichwasextracted
from these cells. RAST is a blood test used to detect speciﬁc
IgE antibodies to suspected or known allergens, in this case,
speciﬁc to food allergens. The IgE antibody is associated with
Type I allergic response. Based on the results of the RAST
test, the patients were classiﬁed into RAST positive (RAST+)
or RAST negative (RAST−). A total of n = 9 RAST− and
n = 12 RAST+ patients were recruited for the study. Table 1
provides demographic and clinical information for the food
RAST+ and RAST− subjects. Comparative analysis was done
between RAST+ and RAST− patient groups using 2D-
DIGE proteomic analysis. Three independent sample pools
from RAST+ versus RAST− patient samples were analyzed
by 2D-DIGE for identifying the diﬀerentially expressed
proteins. Each pooled sample consisted of 3 RAST+ and 3
RAST−patient samples, respectively.
2.2. PBMC Isolation. Peripheral blood leukocytes were
isolated from whole blood using Ficoll-Hpaque gradient
(Amersham-Pharmacia, Piscataway, NJ, Cat number 17-
1440-03). Samples were centrifuged for 30min at 700×g
and 20◦C without applying a brake. The PBMC interface
was carefully removed by pipetting and was washed twice
with PBS/EDTA and resuspended in 2mL of complete
RPMI media and total number of cells counted using a
hemocytometer.
2.3. RNA Extraction. Cytoplasmic RNA is extracted using
Trizol reagent (Invitrogen- Life Technologies, Carlsbad,
Calif) [14]. The amount of RNA is quantitated using a
Nanodrop ND-1000 spectrophotometer (Nanodrop Wilm-
ington, Del) and isolated RNA is stored at −80◦C until used.
2.4.RealTimeQuantitativePCR(Q-PCR). Q-PCRwasused
to quantitate gene expression. RNA is reverse transcribed
to cDNA using the reverse transcriptase kit from Promega
(Promega Inc, Madison, Wis, USA; Cat number A3500).
Relative abundance of each mRNA species is quantitated by
real time quantitative PCR for speciﬁc primers using the
Brilliant SYBR green QPCR master mix from Stratagene
(Stratagene Inc, La Jolla, Calif, USA; Cat number 600548-
51). Relative expression of mRNA species is calculated using
the comparative CT method [15]. All data are controlled for
quantity of RNA input by performing measurements on an
endogenous reference gene, β-actin. In addition, results on
expression levels of diﬀerent genes from Rast+ samples are
normalized to results obtained from Rast− samples. Results
are expressed as transcript accumulation index (TAI) asInternational Journal of Proteomics 3
Table 1: Lists of the clinical and demographic information for subjects enrolled in the study. ∗ Denotes in mm the measure of wheal/ﬂare
in a antigen-speciﬁc skin test done relative to a saline control.
(a) Food rast negative patients.
Pt
num-
ber
Age Gender Ethnicity Clinical H/O Skin test RAST Antigen-speciﬁc IgE
(ng/mL)
1 3 F White Peanut: urticaria and rash
after peanut food challenge Negative: peanut 2/4∗ Negative: peanut and tree nuts
21 5F B l a c k
Tree nut: anaphylaxis
(angioedema, shortness of
breath and abdominal pain)
Not done Negative: peanut and tree nuts
3 1 M White Eczema workup Positive: milk 12/20∗ Negative: egg, milk and wheat
4 2 M Hispanic Eczema workup Negative: egg 5/6∗ Negative: egg
5 3 M Black Fish: urticaria Positive: mixed Whiteﬁsh Negative: tuna, salmon, cod
6 8 F White Cocoa: headache, strawberry:
rash
Positive: cocoa 5/45∗
Negative: fresh strawberry Negative: cocal and strawberry
77 M Not
speciﬁed Peanut: hives, egg: hives Not done Negative: egg, peanut and tree
nuts
8 7 F White Tuna: hives Negative: tuna 4/5∗ (negative) Negative: tuna
99 M Not
speciﬁed Tomato: facial edema Not done Negative: tomato
(b) Food rast positive patients.
Pt
num-
ber
Age Gender Ethnicity Clinical H/O Skin test RAST Antigen-speciﬁc IgE
(ng/mL)
16 M B l a c k
Peanut: angioedema,
shortness of breath and itchy
eyes
Not done Peanut: >100
2 4 M Black Peanut: rash Positive: peanut (5/20)∗ Peanut: 0.86
3 5 F Black Peanut: hives, soy: eczema ﬂair P o s i t i v e :s o y( 5 / 1 0 )a n de g g
(3/7)
Peanut: 7.32, soy: 5.15 and tree
nuts: 4.14–>100
4 3 M Black Peanut: hives Positive: peanut (12/20)∗ Peanut: 72.8
5 2 F White Peanut: eczema ﬂare Positive: peanut (15/40)∗ Peanut: 4.07
6 6 M White Tree nut: diﬃculty breathing Not done Tree nuts: 15–>100
71 6M B l a c k C r a b : a n g i o e d e m a Positive: crab (10/12)∗,l o b s t e r
(10/13)∗ and clam (4/6)∗
Crab: 14.70, Clam: 1.06 and
lobster: 9
84 M Not
speciﬁed Peanut: anaphylaxis Not done Peanut: 9.39
9 11 M Black Cashew: throat itching Positive: cashew (9/9)∗ and
walnut (18/20)∗ Tree nuts: 0.51–9.24
10 16 F Black Peanut: itchy throat Not done Peanut: 20
11 1.5 F Black Egg: anaphylaxis Not done Egg: 62.80
12 9 F White Egg: urticaria Negative Egg: 2.78
described earlier [16]. This calculation assumes that all PCR
reactions are working with 100% eﬃciency.
2.5. Protein Extraction. PBMC isolated from RAST+ and
RAST− subjects were washed twice with 1X PBS (Invitrogen,
Grand Island, NY, USA). Total protein was extracted using
standard cell lysis buﬀer (30mM TrisCl; 8M urea; 4% (w/v)
CHAPS, adjusted to pH 8.5) for 10min on ice. The cell
lysate was centrifuged at 4◦C for 10min at 12000×ga n dw a s
further puriﬁed by precipitation with chloroform/methanol
as described [17]. Samples were resuspended in standard cell
lysis buﬀer. Protein concentrations were determined using
the Coomassie Protein Reagent (Bio-Rad, Hercules, Calif,
USA) prior to DIGE analysis.
2.6. Two-Dimensional Diﬀerence Gel Electrophoresis (2D-
DIGE). The Ettan DIGE technique developed by GE Health-
care (Piscataway, NJ, USA) was used to detect diﬀerences in
protein abundance between the RAST+ and RAST− samples.
The Ettan DIGE system uses 3 CyDye DIGE ﬂuors (Cy2,4 International Journal of Proteomics
Cy3, Cy5), each with a unique ﬂuorescent wavelength,
matched for mass and charge. CyDyes form a covalent
bond with the free epsilon amino group on lysine residues
of the sample proteins. CyDyes label approximately 2%
of the lysine residues. This system allows in each set of
gel 2 experimental samples and an internal standard to
be simultaneously separated on the same gel. The internal
standard is comprised a pool of an equal amount of all
the experimental samples. The use of an internal standard
facilitates accurate inter-gel matching of spots, and allows
for data normalization between gels to minimize gel to gel
experimental variability [12]. Cell lysates were labeled with
CyDye per the manufacturer.All reagents used were from GE
Healthcare (Amersham Biosciences,Piscataway, NJ, USA).
Three independent (n = 3) 2D-DIGE experiments were
done comparing RAST+ and RAST− patient samples. Brieﬂy,
six samples ( 3 RAST+ and 3 RAST−), each of 50μgc e l l
lysate were labeled with 400pmoL of either Cy3 or Cy5,
kept on ice for 30min and then quenched with a 50-fold
molarexcessoffreelysine.50μgofproteinpooledfromequal
amounts of protein from all the six experimental samples
were labeled with Cy2 and used as an internal standard in
each of the three sets of Cy3/Cy5 gels. Cy3-, Cy5-, and Cy2-
labeled samples and unlabelled protein (500–1000μg) were
pooled. Unlabeled protein was added to enhance the protein
staining and hence a better image quality of the SYPRO
ruby staining. An equal volume of 2X sample buﬀer (8M
urea; 2% (v/v) Pharmalytes 3–10; 2% (w/v) dithiothreitol
(DTT); 4% (w/v) CHAPS) was added and incubated on
ice for 10min. The total volume of sample was adjusted
to 450μLw i t hr e h y d r a t i o nb u ﬀer (4% (w/v) CHAPS; 8M
urea; 1% (v/v) Pharmalytes 3–10 nonlinear (NL); 13mM
DTT). Samples were applied to immobilized pH gradient
(IPG) strips (24cm, pH 3–10NL) and absorbed by active
rehydration at 30V for 13hr. Isoelectric focusing was carried
out using an IPGphor IEF system with a 3-phase program;
ﬁrst phase at 500V for 1hr, second phase at 1000V for
1hr, and third phase (linear gradient) 8000V to 64000V
for 2hr (50uA maximum per strip). Prior to separation in
the second dimension, strips were equilibrated for 15min
in equilibration buﬀer I (50mM Tris-HCl, 6M urea, 30%
(v/v) glycerol, 2% (w/v) SDS, 0.5% (w/v) DTT). The strips
were again equilibrated for 15min in equilibration buﬀer II
(50mM Tris-HCl, 6M urea, 30% (v/v) glycerol, 2% (w/v)
SDS, 4.5% (w/v) iodoacetamide) and the equilibrated IPG
strips were transferred onto 18 × 20cm, 12.5% uniform
polyacrylamide gels poured between low ﬂuorescence glass
plates. Gels were bonded to inner plates using Bind-Silane
solution (Promega, Madison, Wis, USA) according to the
manufacturer. Strips were overlaid with 0.9% agarose in
1X running buﬀer containing bromophenol blue and were
run for 16hr (1.8W/gel overnight) at 15◦C in an Ettan
DALT electrophoresis system. After the run was completed,
the 2D gels were scanned 3 times with a Typhoon 9410
imager, each time at diﬀerent excitation wavelengths (Cy3,
532nm; Cy5, 633nm; Cy2, 488nm). Images were cropped
with ImageQuant v5.2 software and then imported into
DeCyderdiﬀerentialin-gelanalysis(DIA)v5.0softwarefrom
GE Healthcare for spot identiﬁcation and normalization of
spot intensities within each gel.
Gels were ﬁxed in 30% (v/v) methanol, 7.5% (v/v) acetic
acid for 3hr and stained with SYPRO-ruby dye (Molecular
Probes, Eugene, Ore, USA) overnight at room temperature.
Gels were destained in water and then scanned using the
Typhoon 9410 scanner. Spots of interest were excised from
the gel using the Ettan Spot Picker. DeCyder software (GE
Healthcare) was speciﬁcally developed for use with the
Ettan DIGE system. DeCyder software allows for automatic
detection of spots, background subtraction, quantitation,
normalization, internal standardization, and integral match-
ing. The diﬀerential in-gel analysis (DIA) component of
DeCyder software draws boundaries around spots in a com-
posite gel image obtained from the intragel overlap of
the Cy2-, Cy3-, and Cy5- scanned images and normalizes
the data from each CyDye to account for diﬀerences in
dye ﬂuorescence intensity and scanner sensitivity. For all
the three sets of experiments (six images), the abundance
diﬀerence between samples (RAST+ and RAST−) run on the
same gel was then analyzed. The biological variation analysis
(BVA) component of DeCyder software was then used to
match all image comparisons from individual Cy3/Cy5 gel
sets for a cross-gel statistical analysis. DeCyder BVA initially
calculates normalized intensities (standard abundance) for
all spots by comparison to the internal standard, and from
this, an average volume ratio and a Student’s paired t-test
derived P value were calculated for each spot. A paired t-
test derived P value of ≤0.05 was considered statistically
signiﬁcant [12].
2.7. Mass Spectrometry and Protein Identiﬁcation. Spots were
excised from 2D-gels loaded with 500 to 1000μgo ft o t a l
proteinandstainedwithSyproruby(MolecularProbes).The
gel plugs were incubated in 200μL of 200mM ammonium
bicarbonate with 50% acetonitrile for 30min at 37◦Ca n d
then dried with a Speed Vac. Samples were then incubated
f o r1ha tr o o mt e m p e r a t u r ei n3 . 5μLo f2 0μg/mL trypsin
(Promega)in40mMammoniumbicarbonate.Anadditional
30μLo f4 0 m Ma m m o n i u mb i c a r b o n a t ew i t h1 0 %a c e -
tonitrile was added and samples were incubated overnight
at 37◦C. The samples were desalted using μ C18 ZipTips
(Millipore, Bedford, Mass, USA) and eluted directly onto
a MTP ground steel 384-target (Bruker Daltonics, Billerica,
Mass, USA) with the matrix solution (a saturated solution of
α-cyano-4-hydroxy-cinnamic acid [CHCA: Bruker Dalton-
ics] dissolved in 0.1% triﬂuoroacetic acid:75% acetonitrile).
MALDI spectra in positive ion mode were obtained using a
Bruker Daltonics Biﬂex IV MALDI-TOF mass spectrometer
operating in the reﬂectron mode. The spectra in the range
of 500–3200Da were obtained by the summation of 50–
200 laser shots. Identiﬁcation and labeling of the peaks
were done manually. External calibration was carried out
using the peptide calibration standard II (700–4000Da)
(Bruker Daltonics, number 222570). Data acquisition was
executed using the Flex Control program (Build 2.4.0.0)
and data processing was performed using the Bruker XTOF
5 software (version 5.1.5). The signatures of proteins ofInternational Journal of Proteomics 5
interest formed by the masses of the products of tryptic
digestion were analyzed using an on-line search engine
MASCOT (http://www.matrixscience.com/) to compare the
calculated masses of a theoretical tryptic digestion. Searches
were conducted for matching masses from theoretical tryptic
peptides from the NCBI protein databases. We used the
following search parameters: monoisotopic masses, with a
tolerance of 200ppm or less (typically 75–100ppm or 0.1–
0.5Da), one missed tryptic cleavage, a carbamidomethyl
modiﬁcationofcysteine(toaccountforiodoacetamidetreat-
ment)andvariablemodiﬁcationsofoxidationofmethionine
and phosphorylation of serine, threonine or tyrosine. A
protein identiﬁcation was considered signiﬁcant for a Mowse
score with P<0.05.
3. Results
3.1. 2D-DIGE Analysis and Protein Identiﬁcation. Protein
proﬁles of RAST− and RAST+ PBMCs were analyzed by
DIGE to examine the diﬀerential expression of proteins
among the two groups. Protein samples from RAST+ and
RAST− PBMC cell lysates were labeled with ﬂuorescent
CyDyes, pooled and analyzed in triplicate by 2D-DIGE. The
pooled mixture of equal amounts of protein from each of
the six experimental samples labeled with Cy2 and run on
every gel provided an internal standard to ensure that every
protein in each sample appears on all of the gels. Each
Cy3- or Cy5-labeled sample was then compared to the same
internal standard and measurements were taken relative
to the internal Cy2 standard, thereby reducing gel-to-gel
variationandincreasingstatisticalconﬁdence.Dye-swapping
was performed to minimize labeling-dependent bias.
The DIA (diﬀerential in-gel analysis) module of the
diﬀerential analysis software DeCyder (GE Healthcare) was
used to calculate protein spot volumes and the normalized
volume ratio for each diﬀerentially labeled comigrated
protein. On an average of about 1000 spots were detected
andmatchedsuccessfullyinthreeRAST+ andRAST− CyDye-
labeled proteome gels (Figure 1). The ratio of spot intensity
of the two groups of protein spots is then calculated.
Gel to gel matching of the standard spot maps from
each gel was performed using the DeCyder BVA software
module. This allowed for the statistical analysis of changes
in protein abundance between samples. Statistical analysis
(paired t-test) was performed for the diﬀerence between
the abundance of proteins from RAST+ cells versus proteins
from and RAST− cells. A total of 52 protein spots showed
a signiﬁcant change in abundance with P<0.05. Proteins
from 37 gel spots were successfully identiﬁed. Figure 2 is the
SYPRO ruby-stained 2D gel image showing all protein spots.
Diﬀerentially expressed protein spots showing signiﬁcant
modulation were selected for subsequent identiﬁcation and
are shown as numbered outlines. The maximum increase
in protein expression was 1.65-fold (spot number 1302 in
Figure 2) and the maximum decrease observed was 10.7-fold
(spot #242, Figure 2).
3.2. MALDI TOF Analysis for Protein Identiﬁcation. Pro-
teomic evaluation of diﬀerential expression of proteins in
PBMCs of RAST+ and RAST− subjects by 2D-DIGE and
MALDI-TOF resulted in a short list of 37 proteins that were
found to be signiﬁcantly modulated (Table 2). The table
lists these proteins and includes their symbols, % sequence
coverage of the identiﬁed peptide, number of matching
peptides, theoretical mass, and calculated pI of the identiﬁed
protein.
3.3. Validation of the Diﬀerentially Expressed Proteins. Hav-
ing shortlisted these key proteins that are diﬀerentially
expressed in the RAST+ and RAST− subjects, we evaluated if
the gene expression levels of these proteins were signiﬁcantly
diﬀerent in these two groups. Based on an exhaustive
literature review and on comparative analysis using gene
expression studies by quantitative PCR, we have highlighted
a group of key proteins that play a role in food allergenicity.
These include chondroitin sulfates, zinc ﬁnger proteins,
C-type lectins, retinoic acid-binding proteins, heat shock
proteins, membrane proteins such as myosin and cytokines
such as IL-17F, certain mast cell expressed proteins, and
signal transduction molecules such as the family of MAP
kinases. Almost all of these proteins play a role in immune
tolerance and hypersensitivity [18–22], and they modulate
cytokine patterns that favor a Th2 response that typically
results in IgE-mediated allergic response. The following are
the gene expression levels of the key proteins that were
signiﬁcantly lower in RAST+ subjects as compared to RAST−
subjects. Heat shock protein-40 homolog (DJC15) (19%
decrease, P = 0.001); C-type lectins (15% decrease; P =
0.006); MAPK (24% decrease; P = 0.0001); retinoic acid-
binding protein (18% decrease; P = 0.002); chondroitin
transferase (15% decrease; P = 0.006); zinc ﬁnger protein
(10%decrease;P = 0.05);IL-17Fprotein(12%decrease;P =
0.02); and MCEM1 mast cell expressed membrane protein 1
(29% decrease; P = 0.0001). The gene expression levels of
cytokine IL-10 were signiﬁcantly higher (50% increase; P =
0.0001) in the RAST+ subjects as compared to the RAST−
subjects. No signiﬁcant diﬀerences in the gene expression
levels of myosin and Ikaros were observed between the 2
patient groups. Figures 3, 4,a n d5 show the fold regulation
in the gene expression levels of these key proteins. Although
the fold changes in gene and protein changes in these key
molecules are not of similar magnitude, the trends in their
expression are in concordance and therefore suggests that
these proteins may play a signiﬁcant role in the development
of food allergies.
3.4. Biological Network Analysis Using MetaCore. Given the
high through put data that emerges from proteomic analysis,
additional data analysis using novel software tools, can be
used to interrogate the biological context of lists of genes
and proteins. We used one such software tool, MetaCore,
which uses a proprietary, manually curated database of
human protein-protein, protein-DNA, and protein com-
pound interactions, metabolic and signaling pathways which
is supported by proprietary ontologies. The transcription6 International Journal of Proteomics
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Figure 1: Representative 2D-DIGE gel images of Cy3 and Cy5 Dye-labeled RAST+ and RAST− samples. Protein samples were labeled with
Cy Dyes and analyzed by 2D-DIGE. (a) RAST− (Cy3); (b) RAST + (Cy5); (c) overlay of Cy3 and Cy5 gel images.
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Figure 2: SYPRO ruby-stained 2-D gel image of a 2D-DIGE separation of RAST+ and RAST− samples. 2-D electrophoresis was performed
using 24 cm, pH 3–10 linear IPG strips and 10% SDS-PAGE gels. Spots that showed statistically signiﬁcant diﬀerences in intensity between
the RAST− and RAST+ are marked. Diﬀerences in Cye Dye-labeled sample abundances were analyzed using DeCyder Software. Diﬀerentially
expressed protein spots with their respective fold diﬀerences and P values are given as a table. A paired t-test derived P value of ≤0.05
was considered statistically signiﬁcant. Protein spots were excised and identiﬁed using MALDI-TOF and the identiﬁed proteins are listed in
Table 2.International Journal of Proteomics 7
Table 2: List of the up/down regulated proteins from RAST+ and RAST− samples analyzed by 2D-DIGE and further identiﬁed by MALDI-
TOF. Data shown in the table include spot number, calculated mass, theoretical pI, number of matching peptides, % sequence coverage,
name and symbol of identiﬁed proteins.
Spot
number Mass PI
value
Peptides
matches
Sequence
coverage
(%)
Protein name Symbol
189 14505 6.81 7 59 40S ribosomal protein S12 RS12 HUMAN
1244 54005 6.21 11 28 6-phosphofructo-2-kinase/fructose-
2,6-biphosphatase 4 F264 HUMAN
1008 35830 6.51 7 32 Aldose reductase ALDR HUMAN
1213 15683 5.42 6 27 Cellular retinoic acid-binding protein 2 RABP2 HUMAN
1302 61312 8.63 8 17 Chondroitin sulfate
N-acetylgalactosaminyltransferase 1 CGAT1 HUMAN
1387 91751 5.98 15 19 Coiled-coil domain-containing protein CF204 HUMAN
1299 83214 7.23 8 17 Complement C2 CO2 HUMAN
1428 36702 8.45 10 39 C-type lectin domain family 4 member K CLC4K HUMAN
963 38901 5.27 9 26 DDB1- and CUL4-associated factor 7 DCAF7 HUMAN
1105 40517 9.00 10 28 Developmentally regulated GTP-binding protein
1 DRG1 HUMAN
1225 30836 8.71 6 18 DnaJ homolog subfamily C member 27 DJC27 HUMAN
416 16373 10.08 7 59 DnaJ(HSP40) homolog DJC15 HUMAN
944 77221 5.36 11 21 Elongation factor G 2 EFG2 RALME
1448 104682 6.08 12 12 Exostosin-like 3 EXTL3 HUMAN
105 81024 6.45 13 20 FACT complex subunit SSRP1 SSRP1 HUMAN
661 16459 8.67 6 51 Globin-1 OS=Petromyzon marinus PE=1S V =2 GLB1 PETMA
1309 37162 10.80 8 31 Heparan sulfate glucosamine
3-O-sulfotransferase6 HS3S6 HUMAN
1080 57528 6.12 14 22 IKAROS zinc ﬁnger protein 1 IKZF1 HUMAN
1513 18033 9.15 6 49 Interleukin-17F IL17F HUMAN
980 129489 7.14 11 12 Laminin subunit beta-3 LAMB3 HUMAN
403 36288 7.08 8 24 L-lactate dehydrogenase C chain LDHC HUMAN
242 47983 9.64 9 23 MAPK/MAK/MRK overlapping kinase MOK HUMAN
1132 21215 9.03 7 24 Mast cell expressed membrane protein 1 MCEM1 HUMAN
684 181570 5.94 13 17 Mitogen-activated protein kinase kinase kinase 4 M3K4 HUMAN
907 121648 9.46 11 14 Myosin-Ic MYO1C HUMAN
1191 60539 9.62 19 28 Paraﬁbromin CDC73 HUMAN
1187 43939 9.33 10 24 Pentatricopeptide repeat-containing protein 2 PTCD2 HUMAN
1090 56852 8.52 10 21 Probable histidyl-tRNA synthetase, mitochondrial SYHM HUMAN
761 50550 5.00 10 34 Rab GDP dissociation inhibitor alpha GDIA HUMAN
983 79767 5.54 13 18 RUN and FYVE domain-containing protein 1 RUFY1 HUMAN
981 12439 10.54 7 73 Somatoliberin SLIB HUMAN
763 33047 6.64 7 31 Tissue factor TF HUMAN
918 23294 11.33 7 44 Transcription factor 23 TCF23 HUMAN
1264 64218 8.56 9 23 Transmembrane anterior posterior
transformation protein 1 homolog TAPT1 HUMAN
1510 121711 5.95 16 22 Transmembrane protein 132C OS T132C HUMAN
1432 23069 9.51 6 38 UPF0684 protein C5orf30 CE030 HUMAN
1367 57986 6.11 8 19 Zinc ﬁnger protein Aiolos IKZF3 HUMAN8 International Journal of Proteomics
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Figure 3: Relative gene expression of heat shock protein-40 homolog (DJC15); C-type lectins, Ikaros; MAPK in RAST+ versus RAST−
Patients as quantitated by QPCR. Gene expression analysis of heat shock protein-40 homolog; C-type lectins, Ikaros; MAPK were done
using RNA extracted from PBMC from RAST+ and RAST− subjects. RNA was reverse transcribed and mRNA expression levels of the above
genes were quantitated using real time QPCR. Relative expression of mRNA species was calculated using the comparative CT method. Data
are the mean ± SD of 3 separate experiments done in duplicate. Data are presented as TAI or the transcript accumulation index. Statistical
signiﬁcance was determined by Student’s t-test based on comparison between the RAST+ versus RAST− patients.
regulation networks of diﬀerentially expressed proteins in
the RAST+ and RAST− groups were generated by MetaCore
software using a transcription regulation algorithm. The
networks were ranked by a P value and interpreted in terms
of GO. The list of signiﬁcantly regulated proteins emerged
after 2D-DIGE/MALDI-TOF analysis of the RAST+ and
RAST− samples, highlighted in Table 2,w a se n t e r e di nt o
MetaCore. The MetaCore software has in-built algorithms
that create biological networks from the uploaded protein
listandassignbiologicalprocessestothegeneratednetworks.
We built these various networks using “Analyze Network”
algorithm of MetaCore which is useful in providing addi-
tional information that is not present in the original list
of root nodes. 37 diﬀerentially expressed proteins identiﬁed
on comparison between the RAST+ and RAST− groups
were mapped into the software and subsequently analyzed.
Networks were generated as per P value, Z-score and G-
score. P value is based on the saturation of each sub-network
with proteins from the user selected list. Z-score ranks the
subnetworks according to saturation with the objects from
the initial list of seed objects. The Z-score ranks the sub-
networks of the analyze network algorithm with regard to
their saturation with proteins from the experiment. The G-
score modiﬁes the Z-score based on the number of canonical
pathways used to build the network. If a network has a high
G-score, it is saturated with expressed proteins (from Z-
score) and it contains many canonical pathways. We chose
the top 3 networks from the search results as ranked by both
G-scoreandP values.Thesigniﬁcanceofassociationbetween
the biological processes and the diﬀerentially expressed
proteins were represented by P values. The list of most
signiﬁcant GO processes associated with the network isInternational Journal of Proteomics 9
RAST −ve RAST +ve
T
A
I
=
2
−
Δ
Δ
C
T
0.4
0.6
0.8
1
1.2
IL-4
P = NS
(a)
0.75
0.8
0.85
0.9
0.95
1
1.05
RAST −ve RAST +ve
T
A
I
=
2
−
Δ
Δ
C
T
IL-17
P = 0.006
(b)
RAST −ve RAST +ve
T
A
I
=
2
−
Δ
Δ
C
T
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
IL-10
P = 0.05
(c)
RAST −ve RAST +ve
T
A
I
=
2
−
Δ
Δ
C
T
0.4
0.5
0.6
0.7
0.8
0.9
1
1.1
P = 0.0001
MAST cell expressed
(d)
Figure 4: Relative gene expression of retinoic acid-binding protein; chondroitin transferase; myosin; zinc ﬁnger protein; in RAST+ versus
RAST−patients as quantitated by QPCR. Gene expression analysis of retinoic acid-binding protein; chondroitin transferase; myosin; zinc
ﬁngerprotein;wasdoneinRNAextractedfromPBMCfromRAST+ andRAST− subjects.RNAwasreversetranscribedandmRNAexpression
levels of the above genes was quantitated using real time QPCR. Relative expression of mRNA species was calculated using the comparative
CT method. Data are the mean ± SD of 3 separate experiments done in duplicate. Data are presented as TAI or the transcript accumulation
index. Statistical signiﬁcance was determined by Student’s t-test based on comparison between the RAST+ and RAST− patients.
shown in Table 3 along with the respective P values. The
top 3 processes, the percentage of target nodes involved
and the corresponding P values are positive regulation of
immune system process (35%, P-value 2.2e − 50), MyD88-
independent toll-like receptor signaling pathway (19.32%,
2.51e − 49) and toll-like receptor 3 signaling pathway
(19.32%, 4.1e − 49). Figure 6 illustrates the close clustering
and interconnectedness of biochemical process networks of
the identiﬁed proteins which are diﬀerentially regulated.
4. Discussion
Allergic responses to food antigens involve a state of
immediate hypersensitivity to certain food proteins. The
mechanism underlying the initiation and development of
allergic responses involves cytokine activation which is be-
lieved to directly induce the diﬀerentiation of eﬀector Th2
lymphocytes; these Th2 responses play a pivotal role in the
development of allergic responses to speciﬁc food antigenic
triggers. In this paper, we utilized a high throughput
proteomic approach, 2D-DIGE, coupled with MALDI-TOF
protein identiﬁcation methods to study the diﬀerential
expression of proteins in two groups of RAST+ and RAST−
subjects with the goal to identify key proteins that may play
a role in the development of food allergenicity. In contrast
to traditional biochemical approaches that can only study
one or a few particular protein species, proteomics analysis
allows the simultaneous analysis of thousands of proteins.
Thisistheﬁrstcomprehensivediﬀerentialproteomicanalysis
of PBMC obtained from RAST+ and RAST− subjects. Over
1,000 distinct proteins were identiﬁed of which about 52
proteins displayed signiﬁcant diﬀerential expression between10 International Journal of Proteomics
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Figure 5: Relative gene expressions of IL-4, IL-17, IL-10, and MCEM1 in RAST+ versus RAST− patients as quantitated by QPCR. Gene
expression analysis of IL-4, IL-17, IL-10, and MCEM1 was done in RNA extracted from PBMC from RAST+ and RAST− subjects. RNA was
reverse transcribed and mRNA expression levels of the above genes were quantitated using real time QPCR. Relative expression of mRNA
species was calculated using the comparative CT or the ΔΔCt method. This method calculates fold changes between each normal sample
and its paired aﬀected sample. ΔCt represents normalized gene expression level (normalized to its own internal control housekeeping gene
β-actin). ΔCt for test and control samples were averaged and compared to obtain the ΔΔCt value (an average value). CV, or coeﬃcient
of variation, is calculated using the formula STDEV/average. Data are the mean ± SD of 3 separate experiments done in duplicate. Data
are presented as TAI or the transcript accumulation index. Statistical signiﬁcance was determined by Student’s t-test based on comparison
between the RAST+ versus RAST− patients.
the RAST+ and RAST− groups. Of these 52 signiﬁcantly
regulated proteins, 37 were successfully identiﬁed (Table 2).
A large proportion of these proteins have direct or indirect
biological relevance to food allergy.
Food allergenicity is characterized by abnormal IgE pro-
duction, peripheral eosinophilia, mast cell activation, and
induction of Th2 lymphocytes expressing cytokines such as
IL-4 and IL-10 [23, 24]. Even though we could not observe
any diﬀerential expression of IL-4 and IL-10 in the 2D-
DIGE analysis, Metacore analysis indicated a very active
involvement of these molecules in the networks. A further
QPCR analysis showed a signiﬁcant increase in IL-10 levels
in RAST+ patients as compared to RAST− patients. IL-10 is
a cytokine that downregulates both Th1 and Th2 cytokine
production [25], and the fact is that its levels are signiﬁcantly
elevated in RAST+ patients and may be useful in identifying
human clinical tolerance to foods. IL-10 is also believed to
help diﬀerentiation of T helper cells into the Th2 phenotype,
therebycontributingtothedevelopmentofallergicresponses
tofoodantigens.IL-4levelsinRAST+ patientswerelowerbut
not statistically signiﬁcant as compared to RAST− patients.
A decrease in IL-4 is believed to impair the development of
food allergy and the aversion to antigen. Production of IL-
4 and levels of speciﬁc IgE/IgG1 antibodies correlate with
aversion to antigen induced by food allergy in mice [26].
The mechanism underlying the initiation and developmentInternational Journal of Proteomics 11
Table 3:Listofthemostsigniﬁcantgeneontology(GO)processesassociatedwiththebiologicalnetworkshowninFigure 6asdeterminedby
MetaCore analysis along with the corresponding P values which indicates that the key protein identiﬁed by proteomic analysis are associated
with the listed biological processes in a prioritized manner.
Number Biological process % involvement in the biological process P value
1 Positive regulation of immune system process 35.23 2.280 e −50
2 MyD88-independent toll-like receptor signaling pathway 19.32 2.516 e −49
3 Toll-like receptor 3 signaling pathway 19.32 4.103 e −49
4 Toll-like receptor signaling pathway 19.89 5.703 e −48
5 Signal transmission via phosphorylation event 32.95 8.113 e −48
6 Intracellular protein kinase cascade 32.95 8.113 e −48
7 Positive regulation of response to stimulus 33.52 3.663 e −47
8 Pattern recognition receptor signaling pathway 19.89 8.743 e −47
9 Activation of innate immune response 19.89 2.639 e −46
10 Innate immune response-activating signal transduction 19.89 2.639 e −46
11 Positive regulation of biological process 63.64 4.550 e −46
12 Positive regulation of defense response 24.43 4.898 e −46
of allergic responses involves IL-4 that directly induces the
diﬀerentiation of committed eﬀector Th2 lymphocytes, and
Th2 responses play a pivotal role in the development of
allergic responses. IL-4 inhibits the induction of Foxp3 and
the generation of inducible regulatory T cells and may also
function as anti-inﬂammatory cytokine [27].
IL 17F is reported to be involved in inﬂammation
and a study on eﬀect of IL-17/IL-17F deﬁciency in an al-
lergic asthma IL-17 KO mice model, exhibited reduced
Th2 cytokine expression, whereas IL-17F KO mice showed
elevatedtype2cytokinesandeosinophilfunctionscompared
with WT mice. This indicates that IL-17 and IL-17F may
have opposite functions in chronic allergic airway diseases
[28]. The precise role of IL-17 and a new population of IL-
17-producing Th cells (Th17) in allergic inﬂammation is
unclear, but Th17 cells are characterized by the production
of inﬂammatory cytokines such as IL-17A, IL-17F, IL-22,
and IL-26 [29]. The highest percentage of IL-17-producing
cells has been found in severe atopic dermatitis, suggesting
a direct correlation between the presence of Th17 cells
and severity of the disease [30], indicating that there is
possible cross-talk between Th17 cells and eosinophils. Our
observation of a signiﬁcant decrease in IL-17 in RAST+
patients is contradictory to what we expected based on its
roleasapromoterofallergicinﬂammation. This observation
leads us to believe that IL-17 may be associated with patterns
of cytokine dysregulation that are associated with speciﬁc
atopic phenotypes, though the precise mechanism of its
modulation is unclear.
Mast cells are believed to be the key eﬀector cells of IgE-
mediated anaphylactic reaction, therefore, a modulation in
the expression of the mast cell expressed protein MCEM1
in RAST+ patients is anticipated. We observed a signiﬁcant
decrease in MCEM1 expression in RAST+ patients. The
MAPK pathway and its downstream eﬀectors play an impor-
tant role in the regulation of cytokine expression in mast
cells. Signals emanating from many cell surface antigenic
receptors and environmental stimuli can converge on the
MAPK pathway, which in turn phosphorylates and acti-
vates various transcriptional factors and molecular eﬀectors,
thereby modulating allergic response. Proteins such as zinc
ﬁnger proteins, retinoic acid-binding proteins, chondroitin
transferase, C-type lectins and heat shock proteins in the
soluble microenvironment are believed to be involved in the
conditioning of antigen presenting cells, thereby promoting
tolerance to dietary antigen primarily via the induction of
regulatory T cells.
Yet another unique protein that is signiﬁcantly modu-
lated in RAST+ patients is Ikaros. This family of proteins
plays an important role in hematopoietic development and
is believed to modulate the levels of an immunosuppres-
sive compound called bis(tributyltin)oxide (TBTO) that is
present in the diet and which can contribute signiﬁcantly
to the development of food allergy to peanut or ovalbumin.
TBTO can decrease allergen-speciﬁc Th2 cytokine produc-
tion, number of eosinophilic and basophilic granulocytes in
the blood and production of mast cell proteases after an oral
food challenge.
To understand the relevance of these proteins and their
role in allergy or overall inﬂammation and to ascertain
their interaction with other proteins in known networks the
identiﬁed proteins were analyzed using Metacore network
building tools. Of the total 37 identiﬁed proteins imported
to Metacore, 20 were successfully mapped in the networks
(Figure 6). The unconnected proteins in the network were
removed. The proteins diﬀerentially regulated in RAST+
subjects were shown in red circles in the network. In
protein network generated using the uploaded, diﬀerentially
expressed proteins in this study showed signiﬁcant links
to inﬂammatory and immunological responses. Among the
upregulated proteins all except Globin-1 could be mapped
on to the network.
5. Conclusion
The current investigation has helped to identify key proteins
involved in food allergenicity that provide evidence for a12 International Journal of Proteomics
Figure 6: The biochemical processes networks of the diﬀerentially expressed proteins generated by MetaCore software using a transcription
regulationalgorithm.ThebiochemicalprocessesregulationnetworkswererankedbyaP valueandinterpretedintermsofGO.Genenetwork
illustrates proteins and interactions of the diﬀerentially expressed proteins in RAST+ and RAST− patients. The network was obtained using
analyze network algorithm of MetaCore and illustrates the close clustering and interconnectedness of biochemical process networks of the
identiﬁeddiﬀerentiallyregulatedproteinsinfoodallergy.Coloredhighlightedsymbols(nodes)representproteins(enzymes(yellowarrows),
transporters (purple shapes), receptor ligands (green shapes), transfactors (red shapes), and other proteins (blue shapes)). Red solid circles
correspondtodiﬀerentiallyexpressedproteinsinRAST+ samplesidentiﬁedbyMALDIanalysis.Bluecirclesshowtheproteinsinthenetwork
withintheimmediatevicinityofthoseidentiﬁedproteins.Thesmallcoloredhexagonsonvectorsbetweennodesdescribepositiveinteraction
(green), unspeciﬁed interactions (black), or logical relationships (blue). Each connection (vector) represents a direct interaction between
proteins.
relationship between Th2 immune response and food allergy
and suggests that these responses play an important role
in the development of food allergy. This study provides
important information about global protein expression in
RAST+ patients with food allergies. Although we could
not subdivide the patients with food allergies into speciﬁc
food type, namely, peanut, egg, shell ﬁsh, and so forth,
the identiﬁcation of these key proteins provides clues to
elucidate mechanisms of the structures that contribute to
allergenicity, which thus, in turn, would help alleviate food
allergens. Further, these key proteins can be utilized as
diagnostic markers that will not only help in the diagnosis
and management of food allergy but also may be used in
future immunotherapy.
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